The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
New Zealand Economy Faces Short-Term Pressure but Recovery Remains on Track
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
US and EU Strengthen Critical Minerals Partnership to Reduce China Dependence
Japan Inflation Rises in March Amid Energy Price Surge and Middle East Tensions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Indian Cotton Yarn Exports Surge as China Demand Rises Amid Global Supply Disruptions
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
U.S.-Iran Conflict Stalls as Diplomatic Efforts Collapse and Global Oil Tensions Rise
Asian Stocks Surge to Record Highs as Wall Street Rally Offsets Oil Price Concerns 



